Octopus Biosafety announces its growth strategy

On September 16, 2025, Octopus Biosafety, a subsidiary of the American group TAW, announced the publication of a Letter to Shareholders. This communication aims to share the company's growth strategy following its merger with TAW. The company's CEO highlights the company's objectives and future initiatives for poultry robotics and facility management.

Octopus Biosafety's shares, listed on Euronext Access Paris under ISIN code FR0013310281 and ticker symbol MLOCT, remain under the watchful eye of investors. For additional details, the Letter to Shareholders is available on the company's website.